Alterome Therapeutics patents new GTPase KRAS inhibitors
Summary
Alterome Therapeutics disclosed patents for new GTPase KRAS inhibitors that may be useful in cancer treatment. The item centers on intellectual property rather than a commercial launch or corporate transaction. This keeps the news relevant to the pharma and life sciences software ecosystem because it reflects ongoing R&D activity in a drug-development company. The announcement does not indicate an immediate buying decision or partner evaluation.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected